申请人:——
公开号:US20040122030A1
公开(公告)日:2004-06-24
The present invention is directed to novel thalidomide derivative compounds that have activity as anti-angiogenic compounds. More particularly the compounds have the general structure: where R
1
is selected from the group consisting of H, halo, alkyl, haloalkyl, —NH
2
, hydroxy and alkoxy; R
2
is selected from the group consisting of optionally substituted bicyclic, optionally substituted aryl, and R
6
is H, or C
1
-C
8
alkyl; R
19
is optionally substituted aryl; and m is 0-6.
1
本发明涉及具有抗血管生成活性的新型沙利度胺衍生物化合物。更具体地说,这些化合物具有以下一般结构: 其中 R
1
选自由 H、卤素、烷基、卤代烷基、-NH
2
、羟基和烷氧基
2
选自由取代的双环化合物、自由取代的芳基化合物和 R
6
是 H 或 C
1
-C
8
烷基;R
19
是任选取代的芳基;m 是 0-6。
1